Pair Name | Aloin, Irinotecan | ||
Phytochemical Name | Aloin (PubChem CID: 12305761 ) | ||
Anticancer drug Name | Irinotecan (PubChem CID: 60838 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Aloin, Irinotecan | |||
Disease Info | [ICD-11: 2B91] | Colorectal cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Phosphorylation | AKT1 | hsa207 |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Cleavage | CASP9 | hsa842 | |
Down-regulation | Expression | IGF1R | hsa3480 | |
Down-regulation | Phosphorylation | MTOR | hsa2475 | |
Up-regulation | Cleavage | PARP1 | hsa142 | |
Down-regulation | Phosphorylation | PIK3CA | hsa5290 | |
In Vitro Model | LoVo | Colon adenocarcinoma | Homo sapiens (Human) | CVCL_0399 |
In Vivo Model | 4×10⁶ LoVo cells were suspended in serum-free Matrigel medium.Control (DMSO), CPT-11(2 mg/Kg), Aloin (20 mg/Kg), and combination (2 mg/Kg CPT-11 + 20 mg/Kg Aloin). The mice were treated via intratumor injection, every 48 h for four weeks. | |||
Result | Our findings suggests that CPT-11 and Aloin are potential combination treatment partners against colorectal cancer. MicroRNA-133b may serve as a co-therapeutic target with IGF1R against colorectal cancer, which might overcome the existing treatment limitations. |
No. | Title | Href |
---|---|---|
1 | Aloin and CPT-11 combination activates miRNA-133b and downregulates IGF1R- PI3K/AKT/mTOR and MEK/ERK pathways to inhibit colorectal cancer progression. Biomed Pharmacother. 2023 Dec 31;169:115911. doi: 10.1016/j.biopha.2023.115911. | Click |